Aveanna Healthcare (NASDAQ:AVAH) CAO Sells $59,195.70 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 7,738 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $7.65, for a total value of $59,195.70. Following the completion of the sale, the chief accounting officer directly owned 323,884 shares of the company’s stock, valued at approximately $2,477,712.60. This represents a 2.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Deborah Stewart also recently made the following trade(s):

• On Thursday, February 19th, Deborah Stewart sold 11,181 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.21, for a total value of $80,615.01.
• On Wednesday, February 18th, Deborah Stewart sold 10,896 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.38, for a total value of $80,412.48.
• On Friday, January 2nd, Deborah Stewart sold 11,962 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total value of $93,901.70.
• On Wednesday, December 31st, Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total transaction of $92,229.50.
• On Tuesday, December 30th, Deborah Stewart sold 11,379 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total transaction of $95,128.44.

Aveanna Healthcare Stock Performance

Shares of Aveanna Healthcare stock traded up $0.02 during trading hours on Thursday, reaching $7.42. The company’s stock had a trading volume of 3,877,110 shares, compared to its average volume of 938,081. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The company’s 50 day simple moving average is $8.48 and its 200 day simple moving average is $8.44. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The stock has a market cap of $1.55 billion, a P/E ratio of 20.61 and a beta of 2.06.

Analyst Ratings Changes

Several research firms have recently commented on AVAH. UBS Group upped their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a report on Thursday, January 15th. Zacks Research lowered Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. BMO Capital Markets initiated coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 target price on the stock. Raymond James Financial reiterated an “outperform” rating and issued a $13.00 target price on shares of Aveanna Healthcare in a research note on Friday, December 5th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $11.06.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Neutral Sentiment: Short-interest data released for Feb. 19 shows an apparent data anomaly (0 shares reported / NaN change), so there’s no clear short‑interest signal to explain price moves today. (Report notes the short‑interest ratio is effectively 0 days based on reported volume.)
• Neutral Sentiment: Market commentary explains recent intraday weakness in AVAH; see a recent write‑up for context on why the stock moved. Why AVAH is Down
• Negative Sentiment: Significant insider selling: over Feb. 17–19 multiple insiders (CEO Jeff Shaner, several executives including CFO Matthew Buckhalter and CAO Deborah Stewart, plus others such as Edwin C. Reisz and Patrick A. Cunningham) sold large blocks. Combined, these filings show roughly 740,000 shares sold across the group — about $5.4–$5.5M in proceeds — at average prices in the ~$7.20–$7.65 range. Collective, high‑profile sales of this size often weigh on near‑term investor sentiment because they increase supply and may be interpreted as insiders taking money off the table. CEO Filings Other Exec Filings

Institutional Trading of Aveanna Healthcare

Large investors have recently added to or reduced their stakes in the business. AustralianSuper Pty Ltd acquired a new position in Aveanna Healthcare during the 3rd quarter worth $15,743,000. Vanguard Group Inc. increased its holdings in shares of Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after purchasing an additional 1,535,351 shares during the period. Millennium Management LLC raised its stake in shares of Aveanna Healthcare by 1,007.1% during the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock valued at $9,107,000 after purchasing an additional 1,014,030 shares in the last quarter. Nuveen LLC lifted its holdings in Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after purchasing an additional 905,316 shares during the period. Finally, Hillsdale Investment Management Inc. bought a new position in Aveanna Healthcare in the 3rd quarter valued at about $7,922,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.